{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:15:30Z","timestamp":1774026930367,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1038\/ncpneuro0421","type":"journal-article","created":{"date-parts":[[2007,3,7]],"date-time":"2007-03-07T12:33:07Z","timestamp":1173270787000},"page":"140-151","source":"Crossref","is-referenced-by-count":318,"title":["X-linked adrenoleukodystrophy"],"prefix":"10.1038","volume":"3","author":[{"given":"Hugo W","family":"Moser","sequence":"first","affiliation":[]},{"given":"Asif","family":"Mahmood","sequence":"additional","affiliation":[]},{"given":"Gerald V","family":"Raymond","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFncpneuro0421_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.101","volume":"49","author":"L Bezman","year":"2001","unstructured":"Bezman L et al. (2001) Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 49: 512\u2013517","journal-title":"Ann Neurol"},{"key":"BFncpneuro0421_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/361726a0","volume":"361","author":"J Mosser","year":"1993","unstructured":"Mosser J et al. (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361: 726\u2013730","journal-title":"Nature"},{"key":"BFncpneuro0421_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ymgme.2004.09.015","volume":"84","author":"S Kemp","year":"2005","unstructured":"Kemp S et al. (2005) Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy. Mol Genet Metab 84: 144\u2013151","journal-title":"Mol Genet Metab"},{"key":"BFncpneuro0421_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1471-4159.1976.tb04462.x","volume":"26","author":"M Igarashi","year":"1976","unstructured":"Igarashi M et al. (1976) Fatty acid abnormality in adrenoleukodystrophy. J Neurochem 26: 851\u2013860","journal-title":"J Neurochem"},{"key":"BFncpneuro0421_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0022-510X(92)90028-J","volume":"110","author":"C Theda","year":"1992","unstructured":"Theda C et al. (1992) Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination. J Neurol Sci 110: 195\u2013204","journal-title":"J Neurol Sci"},{"key":"BFncpneuro0421_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.nbd.2003.08.013","volume":"14","author":"AS Paintlia","year":"2003","unstructured":"Paintlia AS et al. (2003) Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood ALD: implications for potential therapies. Neurobiol Dis 14: 425\u2013439","journal-title":"Neurobiol Dis"},{"key":"BFncpneuro0421_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0022-510X(85)90184-4","volume":"70","author":"CJ Reinecke","year":"1985","unstructured":"Reinecke CJ et al. (1985) The correlation between biochemical and histopathological findings in adrenoleukodystrophy. J Neurol Sci 70: 21\u201338","journal-title":"J Neurol Sci"},{"key":"BFncpneuro0421_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1471-4159.1976.tb01593.x","volume":"27","author":"M Igarashi","year":"1976","unstructured":"Igarashi M et al. (1976) Brain gangliosides in adrenoleukodystrophy. J Neurochem 27: 327\u2013328","journal-title":"J Neurochem"},{"key":"BFncpneuro0421_CR9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/j.1471-4159.1991.tb02003.x","volume":"56","author":"OA Bizzozero","year":"1991","unstructured":"Bizzozero OA et al. (1991) Fatty acid composition of human myelin proteolipid protein in peroxisomal disorders. J Neurochem 56: 872\u2013878","journal-title":"J Neurochem"},{"key":"BFncpneuro0421_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U","volume":"45","author":"AB Moser","year":"1999","unstructured":"Moser AB et al. (1999) Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol 45: 100\u2013110","journal-title":"Ann Neurol"},{"key":"BFncpneuro0421_CR11","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/j.1471-4159.1981.tb01698.x","volume":"36","author":"S Tsuji","year":"1981","unstructured":"Tsuji S et al. (1981) Abnormality of long-chain fatty acids in erythrocyte membrane sphingomyelin from patients with adrenoleukodystrophy. J Neurochem 36: 1046\u20131049","journal-title":"J Neurochem"},{"key":"BFncpneuro0421_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ana.410070607","volume":"7","author":"HW Moser","year":"1980","unstructured":"Moser HW et al. (1980) Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. Ann Neurol 7: 542\u2013549","journal-title":"Ann Neurol"},{"key":"BFncpneuro0421_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1203\/00006450-198203000-00002","volume":"16","author":"HW Moser","year":"1982","unstructured":"Moser HW et al. (1982) The prenatal diagnosis of adrenoleukodystrophy. Demonstration of increased hexacosanoic acid levels in cultured amniocytes and fetal adrenal gland. Pediatr Res 16: 172\u2013175","journal-title":"Pediatr Res"},{"key":"BFncpneuro0421_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1203\/00006450-198403000-00016","volume":"18","author":"I Singh","year":"1984","unstructured":"Singh I et al. (1984) Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes. Pediatr Res 18: 286\u2013290","journal-title":"Pediatr Res"},{"key":"BFncpneuro0421_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1399-0004.1986.tb00511.x","volume":"29","author":"A Poulos","year":"1986","unstructured":"Poulos A et al. (1986) Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants. Clin Genet 29: 397\u2013408","journal-title":"Clin Genet"},{"key":"BFncpneuro0421_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/3242","volume":"4","author":"S Kemp","year":"1998","unstructured":"Kemp S et al. (1998) Gene redundancy and pharmacological gene therapy: implications for X- linked adrenoleukodystrophy. Nat Med 4: 1261\u20131268","journal-title":"Nat Med"},{"key":"BFncpneuro0421_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0009-8981(87)90428-1","volume":"166","author":"RJ Wanders","year":"1987","unstructured":"Wanders RJ et al. (1987) Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders. Clin Chim Acta 166: 255\u2013263","journal-title":"Clin Chim Acta"},{"key":"BFncpneuro0421_CR18","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1073\/pnas.81.13.4203","volume":"81","author":"I Singh","year":"1984","unstructured":"Singh I et al. (1984) Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci USA 81: 4203\u20134207","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneuro0421_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1749-6632.1996.tb18610.x","volume":"804","author":"T Hashimoto","year":"1996","unstructured":"Hashimoto T (1996) Peroxisomal beta-oxidation: enzymology and molecular biology. Ann NY Acad Sci 804: 86\u201398","journal-title":"Ann NY Acad Sci"},{"key":"BFncpneuro0421_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ymgme.2004.08.016","volume":"83","author":"RJ Wanders","year":"2004","unstructured":"Wanders RJ (2004) Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol Genet Metab 83: 16\u201327","journal-title":"Mol Genet Metab"},{"key":"BFncpneuro0421_CR21","doi-asserted-by":"publisher","first-page":"30360","DOI":"10.1074\/jbc.271.48.30360","volume":"271","author":"A Uchiyama","year":"1996","unstructured":"Uchiyama A et al. (1996) Molecular cloning of cDNA encoding rat very long-chain acyl-CoA synthetase. J Biol Chem 271: 30360\u201330365","journal-title":"J Biol Chem"},{"key":"BFncpneuro0421_CR22","doi-asserted-by":"publisher","first-page":"7647","DOI":"10.1073\/pnas.85.20.7647","volume":"85","author":"O Lazo","year":"1988","unstructured":"Lazo O et al. (1988) Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Proc Natl Acad Sci USA 85: 7647\u20137651","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 2","key":"BFncpneuro0421_CR23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01804228","volume":"11","author":"RJ Wanders","year":"1988","unstructured":"Wanders RJ et al. (1988) X-linked adrenoleukodystrophy: identification of the primary defect at the level of a deficient peroxisomal very long chain fatty acyl-CoA synthetase using a newly developed method for the isolation of peroxisomes from skin fibroblasts. J Inherit Metab Dis 11 (Suppl 2): 173\u2013177","journal-title":"J Inherit Metab Dis"},{"key":"BFncpneuro0421_CR24","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1128\/MCB.23.2.744-753.2003","volume":"23","author":"MC McGuinness","year":"2003","unstructured":"McGuinness MC et al. (2003) Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy. Mol Cell Biol 23: 744\u2013753","journal-title":"Mol Cell Biol"},{"key":"BFncpneuro0421_CR25","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/hmg\/ddi125","volume":"14","author":"I Oezen","year":"2005","unstructured":"Oezen I et al. (2005) Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency. Hum Mol Genet 14: 1127\u20131137","journal-title":"Hum Mol Genet"},{"key":"BFncpneuro0421_CR26","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/oxfordjournals.jbchem.a133578","volume":"90","author":"S Tsuji","year":"1981","unstructured":"Tsuji S et al. (1981) Increased synthesis of hexacosanoic acid (C26:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). Biochem J (Tokyo) 90: 1233\u20131236","journal-title":"Biochem J (Tokyo)"},{"key":"BFncpneuro0421_CR27","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1172\/JCI118182","volume":"96","author":"JK Ho","year":"1995","unstructured":"Ho JK et al. (1995) Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest 96: 1455\u20131463","journal-title":"J Clin Invest"},{"key":"BFncpneuro0421_CR28","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1194\/jlr.M200041-JLR200","volume":"43","author":"JK Choi","year":"2002","unstructured":"Choi JK et al. (2002) Interactions of very long-chain saturated fatty acids with serum albumin. J Lipid Res 43: 1000\u20131010","journal-title":"J Lipid Res"},{"key":"BFncpneuro0421_CR29","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1073\/pnas.78.8.5066","volume":"78","author":"BR Migeon","year":"1981","unstructured":"Migeon BR et al. (1981) Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells. Proc Natl Acad Sci USA 78: 5066\u20135070","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneuro0421_CR30","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","volume":"42","author":"M Dean","year":"2001","unstructured":"Dean M et al. (2001) The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42: 1007\u20131017","journal-title":"J Lipid Res"},{"key":"BFncpneuro0421_CR31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/hmg\/8.5.907","volume":"8","author":"A Netik","year":"1999","unstructured":"Netik A et al. (1999) Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. Hum Mol Genet 8: 907\u2013913","journal-title":"Hum Mol Genet"},{"key":"BFncpneuro0421_CR32","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1093\/hmg\/ddh323","volume":"13","author":"A Pujol","year":"2004","unstructured":"Pujol A et al. (2004) Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum Mol Genet 13: 2997\u20133006","journal-title":"Hum Mol Genet"},{"key":"BFncpneuro0421_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0171-9335(98)80121-0","volume":"75","author":"N Troffer-Charlier","year":"1998","unstructured":"Troffer-Charlier N et al. (1998) Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines. Eur J Cell Biol 75: 254\u2013264","journal-title":"Eur J Cell Biol"},{"key":"BFncpneuro0421_CR34","unstructured":"X-linked Adrenoleukodystrophy Database [ www.x-ald.nl ]"},{"key":"BFncpneuro0421_CR35","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/humu.1227","volume":"18","author":"S Kemp","year":"2001","unstructured":"Kemp S et al. (2001) ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat 18: 499\u2013515","journal-title":"Hum Mutat"},{"key":"BFncpneuro0421_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/hmg\/3.2.265","volume":"3","author":"J Mosser","year":"1994","unstructured":"Mosser J et al. (1994) The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet 3: 265\u2013271","journal-title":"Hum Mol Genet"},{"key":"BFncpneuro0421_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1006\/mgme.1998.2789","volume":"66","author":"LT Braiterman","year":"1999","unstructured":"Braiterman LT et al. (1999) Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression. Mol Genet Metab 66: 91\u201399","journal-title":"Mol Genet Metab"},{"issue":"5","key":"BFncpneuro0421_CR38","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00424-006-0142-x","volume":"453","author":"Ronald J. A. Wanders","year":"2006","unstructured":"Wanders RJ et al. (2006) The peroxisomal ABC transporter family. Pflugers Arch [doi: 10.1007\/s00424-006-0142-x]","journal-title":"Pfl\u00fcgers Archiv - European Journal of Physiology"},{"key":"BFncpneuro0421_CR39","first-page":"3257","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"HW Moser","year":"2001","unstructured":"Moser HW et al. (2001) X-linked adrenoleukodystrophy. In The Metabolic and Molecular Bases of Inherited Disease, edn 8, 3257\u20133301 (Eds Scriver CR et al.) New York: McGraw-Hill"},{"key":"BFncpneuro0421_CR40","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/BF01799621","volume":"15","author":"HW Moser","year":"1992","unstructured":"Moser HW et al. (1992) Adrenoleukodystrophy: phenotypic variability and implications for therapy. J Inherit Metab Dis 15: 645\u2013664","journal-title":"J Inherit Metab Dis"},{"key":"BFncpneuro0421_CR41","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1023\/A:1022535930009","volume":"24","author":"KD Smith","year":"1999","unstructured":"Smith KD et al. (1999) X-linked adrenoleukodystrophy: genes, mutations, and phenotypes. Neurochem Res 24: 521\u2013535","journal-title":"Neurochem Res"},{"key":"BFncpneuro0421_CR42","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/archneur.1975.00490510033001","volume":"32","author":"HH Schaumburg","year":"1975","unstructured":"Schaumburg HH et al. (1975) Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol 32: 577\u2013591","journal-title":"Arch Neurol"},{"key":"BFncpneuro0421_CR43","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/jnen\/60.10.1004","volume":"60","author":"M Ito","year":"2001","unstructured":"Ito M et al. (2001) Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol 60: 1004\u20131019","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncpneuro0421_CR44","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/00005072-199211000-00007","volume":"51","author":"JM Powers","year":"1992","unstructured":"Powers JM et al. (1992) The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 51: 630\u2013643","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncpneuro0421_CR45","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/01.jnen.0000190064.28559.a4","volume":"64","author":"JM Powers","year":"2005","unstructured":"Powers JM et al. (2005) Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol 64: 1067\u20131079","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncpneuro0421_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF00312873","volume":"213","author":"H Budka","year":"1976","unstructured":"Budka H et al. (1976) Spastic paraplegia associated with Addison's disease: adult variant of adreno-leukodystrophy. J Neurol 213: 237\u2013250","journal-title":"J Neurol"},{"key":"BFncpneuro0421_CR47","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/WNL.27.12.1107","volume":"27","author":"JW Griffin","year":"1977","unstructured":"Griffin JW et al. (1977) Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology 27: 1107\u20131113","journal-title":"Neurology"},{"key":"BFncpneuro0421_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/jnen\/59.2.89","volume":"59","author":"JM Powers","year":"2000","unstructured":"Powers JM et al. (2000) Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol 59: 89\u2013102","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncpneuro0421_CR49","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/jnen\/60.5.493","volume":"60","author":"JM Powers","year":"2001","unstructured":"Powers JM et al. (2001) The dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria. J Neuropathol Exp Neurol 60: 493\u2013501","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncpneuro0421_CR50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1212\/01.WNL.0000149514.13580.84","volume":"64","author":"P Dubey","year":"2005","unstructured":"Dubey P et al. (2005) Spectroscopic evidence of cerebral axonopathy in patients with 'pure' adrenomyeloneuropathy. Neurology 64: 304\u2013310","journal-title":"Neurology"},{"key":"BFncpneuro0421_CR51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.61.2.181","volume":"61","author":"V Chaudhry","year":"1996","unstructured":"Chaudhry V et al. (1996) Nerve conduction studies in adrenomyeloneuropathy. J Neurol Neurosurg Psychiatry 61: 181\u2013185","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0421_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1212\/WNL.46.1.112","volume":"46","author":"BM van Geel","year":"1996","unstructured":"van Geel BM et al. (1996) Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study. Neurology 46: 112\u2013118","journal-title":"Neurology"},{"key":"BFncpneuro0421_CR53","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/1531-8249(20010201)49:2<186::AID-ANA38>3.0.CO;2-R","volume":"49","author":"BM van Geel","year":"2001","unstructured":"van Geel BM et al. (2001) Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol 49: 186\u2013194","journal-title":"Ann Neurol"},{"key":"BFncpneuro0421_CR54","unstructured":"Case records of the Massachusetts General Hospital (1979) Weekly clinicopathological exercises. Case 18-1979. N Engl J Med 300: 1037\u20131045"},{"key":"BFncpneuro0421_CR55","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/BF02190668","volume":"153","author":"P Jorge","year":"1994","unstructured":"Jorge P et al. (1994) X-linked adrenoleukodystrophy in patients with idiopathic Addison disease. Eur J Pediatr 153: 594\u2013597","journal-title":"Eur J Pediatr"},{"key":"BFncpneuro0421_CR56","first-page":"353","volume":"3","author":"JM Powers","year":"1980","unstructured":"Powers JM et al. (1980) A correlative study of the adrenal cortex in adreno-leukodystrophy\u2014evidence for a fatal intoxication with very long chain saturated fatty acids. Invest Cell Pathol 3: 353\u2013376","journal-title":"Invest Cell Pathol"},{"key":"BFncpneuro0421_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1006\/mgme.1998.2779","volume":"66","author":"CD Boehm","year":"1999","unstructured":"Boehm CD et al. (1999) Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. Mol Genet Metab 66: 128\u2013136","journal-title":"Mol Genet Metab"},{"key":"BFncpneuro0421_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/archneur.63.1.69","volume":"63","author":"C Cox","year":"2006","unstructured":"Cox C et al. (2006) Cognitive evaluation of neurologically asymptomatic boys with X-linked adrenoleukodystrophy. Arch Neurol 63: 69\u201373","journal-title":"Arch Neurol"},{"key":"BFncpneuro0421_CR59","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000112170","volume":"13","author":"HW Moser","year":"1991","unstructured":"Moser HW et al. (1991) Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci 13: 254\u2013261","journal-title":"Dev Neurosci"},{"key":"BFncpneuro0421_CR60","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/brain\/120.7.1139","volume":"120","author":"D Restuccia","year":"1997","unstructured":"Restuccia D et al. (1997) Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement. Brain 120: 1139\u20131148","journal-title":"Brain"},{"key":"BFncpneuro0421_CR61","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1212\/01.WNL.0000059546.15529.CB","volume":"60","author":"A Fatemi","year":"2003","unstructured":"Fatemi A et al. (2003) MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy. Neurology 60: 1301\u20131307","journal-title":"Neurology"},{"key":"BFncpneuro0421_CR62","first-page":"856","volume":"82","author":"SS el-Deiry","year":"1997","unstructured":"el-Deiry SS et al. (1997) Assessment of adrenal function in women heterozygous for adrenoleukodystrophy. J Clin Endocrinol Metab 82: 856\u2013860","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneuro0421_CR63","first-page":"151","volume":"111","author":"JM Powers","year":"1987","unstructured":"Powers JM et al. (1987) Pathologic findings in adrenoleukodystrophy heterozygotes. Arch Pathol Lab Med 111: 151\u2013153","journal-title":"Arch Pathol Lab Med"},{"key":"BFncpneuro0421_CR64","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0197-0186(03)00162-1","volume":"44","author":"A Di Biase","year":"2004","unstructured":"Di Biase A et al. (2004) Free radical release in C6 glial cells enriched in hexacosanoic acid: implication for X-linked adrenoleukodystrophy pathogenesis. Neurochem Int 44: 215\u2013221","journal-title":"Neurochem Int"},{"key":"BFncpneuro0421_CR65","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbadis.2003.10.004","volume":"1688","author":"CR Vargas","year":"2004","unstructured":"Vargas CR et al. (2004) Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta 1688: 26\u201332","journal-title":"Biochim Biophys Acta"},{"key":"BFncpneuro0421_CR66","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/jnen\/59.12.1063","volume":"59","author":"AG Gilg","year":"2000","unstructured":"Gilg AG et al. (2000) Inducible nitric oxide synthase in the central nervous system of patients with X-adrenoleukodystrophy. J Neuropathol Exp Neurol 59: 1063\u20131069","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncpneuro0421_CR67","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1600-065X.1999.tb01373.x","volume":"172","author":"DB Moody","year":"1999","unstructured":"Moody DB et al. (1999) The molecular basis of CD1-mediated presentation of lipid antigens. Immunol Rev 172: 285\u2013296","journal-title":"Immunol Rev"},{"key":"BFncpneuro0421_CR68","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1212\/01.wnl.0000196491.42058.6f","volume":"66","author":"M Linnebank","year":"2006","unstructured":"Linnebank M et al. (2006) Methionine metabolism and phenotypic variability in X-linked adrenoleukodystrophy. Neurology 66: 442\u2013443","journal-title":"Neurology"},{"key":"BFncpneuro0421_CR69","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1001\/jama.294.24.3131","volume":"294","author":"HW Moser","year":"2005","unstructured":"Moser HW et al. (2005) Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA 294: 3131\u20133134","journal-title":"JAMA"},{"key":"BFncpneuro0421_CR70","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1096-7192(03)00098-2","volume":"79","author":"F Valianpour","year":"2003","unstructured":"Valianpour F et al. (2003) Analysis of very long chain fatty acids using electrospray ionization mass spectrometry. Mol Genet Metab 79: 189\u2013196","journal-title":"Mol Genet Metab"},{"key":"BFncpneuro0421_CR71","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0022-3476(83)80775-6","volume":"103","author":"HW Moser","year":"1983","unstructured":"Moser HW et al. (1983) Identification of female carriers of adrenoleukodystrophy. J Pediatr 103: 54\u201359","journal-title":"J Pediatr"},{"key":"BFncpneuro0421_CR72","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/(SICI)1097-0223(199901)19:1<46::AID-PD501>3.0.CO;2-E","volume":"19","author":"AB Moser","year":"1999","unstructured":"Moser AB and Moser HW (1999) The prenatal diagnosis of X-linked adrenoleukodystrophy. Prenat Diagn 19: 46\u201348","journal-title":"Prenat Diagn"},{"key":"BFncpneuro0421_CR73","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1148\/radiology.165.2.3659373","volume":"165","author":"AJ Kumar","year":"1987","unstructured":"Kumar AJ et al. (1987) Adrenoleukodystrophy: correlating MR imaging with CT. Radiology 165: 497\u2013504","journal-title":"Radiology"},{"key":"BFncpneuro0421_CR74","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1212\/01.WNL.0000079050.91337.83","volume":"61","author":"DJ Loes","year":"2003","unstructured":"Loes DJ et al. (2003) Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 61: 369\u2013374","journal-title":"Neurology"},{"key":"BFncpneuro0421_CR75","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1212\/WNL.58.6.901","volume":"58","author":"FS Eichler","year":"2002","unstructured":"Eichler FS et al. (2002) Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy. Neurology 58: 901\u2013907","journal-title":"Neurology"},{"key":"BFncpneuro0421_CR76","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1212\/01.WNL.0000150906.52208.E7","volume":"64","author":"G Oz","year":"2005","unstructured":"Oz G et al. (2005) Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Neurology 64: 434\u2013441","journal-title":"Neurology"},{"key":"BFncpneuro0421_CR77","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/ana.20643","volume":"58","author":"P Dubey","year":"2005","unstructured":"Dubey P et al. (2005) Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy. Ann Neurol 58: 758\u2013766","journal-title":"Ann Neurol"},{"key":"BFncpneuro0421_CR78","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1212\/01.WNL.0000164458.02141.06","volume":"64","author":"A Fatemi","year":"2005","unstructured":"Fatemi A et al. (2005) Magnetization transfer MRI demonstrates spinal cord pathology in adrenomyeloneuropathy. Neurology 64: 1739\u20131745","journal-title":"Neurology"},{"key":"BFncpneuro0421_CR79","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1067\/mpd.2003.201","volume":"142","author":"MM McGovern","year":"2003","unstructured":"McGovern MM et al. (2003) Biochemical effect of intravenous arginine butyrate in X-linked adrenoleukodystrophy. J Pediatr 142: 709\u2013713","journal-title":"J Pediatr"},{"key":"BFncpneuro0421_CR80","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1006\/mgme.2000.2977","volume":"69","author":"GS Pai","year":"2000","unstructured":"Pai GS et al. (2000) Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients. Mol Genet Metab 69: 312\u2013322","journal-title":"Mol Genet Metab"},{"key":"BFncpneuro0421_CR81","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1124\/mol.63.6.1296","volume":"63","author":"S Fourcade","year":"2003","unstructured":"Fourcade S et al. (2003) Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2). Mol Pharmacol 63: 1296\u20131303","journal-title":"Mol Pharmacol"},{"key":"BFncpneuro0421_CR82","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1525-0016(03)00002-9","volume":"7","author":"S Benhamida","year":"2003","unstructured":"Benhamida S et al. (2003) Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD\/SCID mice. Mol Ther 7: 317\u2013324","journal-title":"Mol Ther"},{"key":"BFncpneuro0421_CR83","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jpeds.2004.10.067","volume":"146","author":"P Dubey","year":"2005","unstructured":"Dubey P et al. (2005) Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long chain fatty acid screening. J Pediatr 146: 528\u2013532","journal-title":"J Pediatr"},{"key":"BFncpneuro0421_CR84","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/jnnp.74.6.822","volume":"74","author":"LX Zhang","year":"2003","unstructured":"Zhang LX et al. (2003) Clinical and electrophysiological improvement of adrenomyeloneuropathy with steroid treatment. J Neurol Neurosurg Psychiatry 74: 822\u2013823","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0421_CR85","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1212\/WNL.39.11.1415","volume":"39","author":"WB Rizzo","year":"1989","unstructured":"Rizzo WB et al. (1989) Dietary erucic acid therapy for X-linked adrenoleukodystrophy. Neurology 39: 1415\u20131422","journal-title":"Neurology"},{"key":"BFncpneuro0421_CR86","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/jnnp.67.3.290","volume":"67","author":"BM van Geel","year":"1999","unstructured":"van Geel BM et al. (1999) Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with 'Lorenzo's oil'. J Neurol Neurosurg Psychiatry 67: 290\u2013299","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0421_CR87","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000112173","volume":"13","author":"G Uziel","year":"1991","unstructured":"Uziel G et al. (1991) Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci 13: 274\u2013279","journal-title":"Dev Neurosci"},{"key":"BFncpneuro0421_CR88","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1056\/NEJM199309093291101","volume":"329","author":"P Aubourg","year":"1993","unstructured":"Aubourg P et al. (1993) A two-year trial of oleic and erucic acids ('Lorenzo's oil') as treatment for adrenomyeloneuropathy. N Engl J Med 329: 745\u2013752","journal-title":"N Engl J Med"},{"key":"BFncpneuro0421_CR89","first-page":"149","volume-title":"Adrenoleukodystrophy and other Peroxisomal Disorders","author":"WB Rizzo","year":"1990","unstructured":"Rizzo WB et al. (1990) X-linked adrenoleukodystrophy: biochemical and clinical efficacy of dietary erucic acid therapy. In Adrenoleukodystrophy and other Peroxisomal Disorders, 149\u2013162 (Eds Uziel G et al.) Amsterdam: Excerpta Medica"},{"key":"BFncpneuro0421_CR90","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/archneur.62.7.1073","volume":"62","author":"HW Moser","year":"2005","unstructured":"Moser HW et al. (2005) Follow-up of 89 Lorenzo's Oil treated asymptomatic adrenoleukodystrophy patients. Arch Neurol 62: 1073\u20131080","journal-title":"Arch Neurol"},{"key":"BFncpneuro0421_CR91","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1182\/blood-2003-10-3402","volume":"104","author":"C Peters","year":"2004","unstructured":"Peters C et al. (2004) Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104: 881\u2013888","journal-title":"Blood"},{"key":"BFncpneuro0421_CR92","first-page":"28","volume-title":"Understanding and Treating Adrenoleukodystrophy. Present State and Future Perspectives","author":"W Koehler","year":"2005","unstructured":"Koehler W and Sokolowski P (2005) Clinical phenotypes, diagnosis and treatment of adulthood X-linked adrenoleukodystrophy. In Understanding and Treating Adrenoleukodystrophy. Present State and Future Perspectives, 28\u201360 (Eds Berger J et al.) SPS Verlagsgessellschaft: Heilbronn"},{"key":"BFncpneuro0421_CR93","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJM199006283222607","volume":"322","author":"P Aubourg","year":"1990","unstructured":"Aubourg P et al. (1990) Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 322: 1860\u20131866","journal-title":"N Engl J Med"},{"key":"BFncpneuro0421_CR94","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0140-6736(00)02629-5","volume":"356","author":"E Shapiro","year":"2000","unstructured":"Shapiro E et al. (2000) Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 356: 713\u2013718","journal-title":"Lancet"},{"key":"BFncpneuro0421_CR95","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.3276004","volume":"239","author":"WF Hickey","year":"1988","unstructured":"Hickey WF and Kimura H (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239: 290\u2013292","journal-title":"Science"},{"key":"BFncpneuro0421_CR96","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/00005072-199309000-00004","volume":"52","author":"ER Unger","year":"1993","unstructured":"Unger ER et al. (1993) Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study. J Neuropathol Exp Neurol 52: 460\u2013470","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncpneuro0421_CR97","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0022-3476(97)80076-5","volume":"131","author":"MJ Nowaczyk","year":"1997","unstructured":"Nowaczyk MJ et al. (1997) Immunoablation does not delay the neurologic progression of X-linked adrenoleukodystrophy. J Pediatr 131: 453\u2013455","journal-title":"J Pediatr"},{"issue":"Suppl 9","key":"BFncpneuro0421_CR98","first-page":"52a","volume":"58","author":"A Mahmood","year":"2005","unstructured":"Mahmood A et al. (2005) Evaluating survival in nontransplanted boys with the cerebral phenotype of X-linked adrenoleukodystrophy [abstract]. Ann Neurol 58 (Suppl 9): 52a","journal-title":"Ann Neurol"},{"key":"BFncpneuro0421_CR99","first-page":"1761","volume":"15","author":"DJ Loes","year":"1994","unstructured":"Loes DJ et al. (1994) Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 15: 1761\u20131766","journal-title":"AJNR Am J Neuroradiol"},{"key":"BFncpneuro0421_CR100","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ymgme.2006.05.001","volume":"89","author":"WC Hubbard","year":"2006","unstructured":"Hubbard WC et al. (2006) Combined liquid chromatography\u2013tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. Mol Genet Metab 89: 185\u2013187","journal-title":"Mol Genet Metab"}],"container-title":["Nature Clinical Practice Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0421","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpneuro0421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T17:14:12Z","timestamp":1736874852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BFncpneuro0421"],"URL":"https:\/\/doi.org\/10.1038\/ncpneuro0421","relation":{},"ISSN":["1745-834X","1745-8358"],"issn-type":[{"value":"1745-834X","type":"print"},{"value":"1745-8358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}